- Home
- KRMD vs VIGL Comparison
KRMD vs VIGL Comparison
Compare KRMD & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- VIGL
- Stock Information
- Founded
- KRMD 1980
- VIGL 2020
- Country
- KRMD United States
- VIGL United States
- Employees
- KRMD N/A
- VIGL N/A
- Industry
- KRMD Medical/Dental Instruments
- VIGL Biotechnology: Pharmaceutical Preparations
- Sector
- KRMD Health Care
- VIGL Health Care
- Exchange
- KRMD Nasdaq
- VIGL Nasdaq
- Market Cap
- KRMD 134.3M
- VIGL 134.9M
- IPO Year
- KRMD N/A
- VIGL 2022
- Fundamental
- Price
- KRMD $3.46
- VIGL $8.05
- Analyst Decision
- KRMD Strong Buy
- VIGL Buy
- Analyst Count
- KRMD 4
- VIGL 7
- Target Price
- KRMD $4.63
- VIGL $8.00
- AVG Volume (30 Days)
- KRMD 416.2K
- VIGL 714.4K
- Earning Date
- KRMD 08-06-2025
- VIGL 08-12-2025
- Dividend Yield
- KRMD N/A
- VIGL N/A
- EPS Growth
- KRMD N/A
- VIGL N/A
- EPS
- KRMD N/A
- VIGL N/A
- Revenue
- KRMD $35,083,740.00
- VIGL N/A
- Revenue This Year
- KRMD $18.16
- VIGL N/A
- Revenue Next Year
- KRMD $14.60
- VIGL N/A
- P/E Ratio
- KRMD N/A
- VIGL N/A
- Revenue Growth
- KRMD 19.65
- VIGL N/A
- 52 Week Low
- KRMD $1.86
- VIGL $1.31
- 52 Week High
- KRMD $5.05
- VIGL $8.10
- Technical
- Relative Strength Index (RSI)
- KRMD 52.54
- VIGL 80.45
- Support Level
- KRMD $3.38
- VIGL $8.03
- Resistance Level
- KRMD $3.64
- VIGL $8.09
- Average True Range (ATR)
- KRMD 0.20
- VIGL 0.03
- MACD
- KRMD -0.01
- VIGL -0.08
- Stochastic Oscillator
- KRMD 60.11
- VIGL 54.55
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.